Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors, whereas semaglutide targets only GLP-1 and tirzepatide targets GLP-1 and GIP
I've already had a knee replacement and the second one is happening on the left knee in a few months
The timeline varies based on individual factors including starting weight, presence of sleep apnea, and sensitivity to the medication adjustment period
The science: why GLP-1 medications change your gut Semaglutide is a GLP-1 receptor agonist
Many users find that patience during this phase pays dividends in tolerability throughout treatment
You receive: Personalized dosing plans Ongoing clinician support Transparent, predictable pricing Medication shipped directly to your door This allows more patients to access evidence-based weight loss support without brand-name medication pricing barriers